dobutamine has been researched along with sq-11725 in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fan, TM; Frantz, RP; Guthinger, L; Liang, CS; Sakamoto, S; Suematsu, M; Sullebarger, JT | 1 |
Gulliver, PA; Raxworthy, MJ; Youde, IR | 1 |
Horinouchi, T; Koike, K | 1 |
Montpetit, CJ; Perry, SF | 1 |
8 other study(ies) available for dobutamine and sq-11725
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Chronic beta-adrenoceptor blockade prevents the development of beta-adrenergic subsensitivity in experimental right-sided congestive heart failure in dogs.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Aorta; Blood Pressure; Dobutamine; Dogs; Heart Failure; Heart Rate; Isoproterenol; Myocardial Contraction; Myocardium; Nadolol; Norepinephrine; Receptors, Adrenergic, beta | 1991 |
Catechol-O-methyltransferase: substrate-specificity and stereoselectivity for beta-adrenoceptor agents.
Topics: Adrenergic beta-Antagonists; Animals; Catechol O-Methyltransferase; Dobutamine; Isoetharine; Isoproterenol; Kinetics; Methylation; Nadolol; Norepinephrine; Piperidines; Propanolamines; Receptors, Adrenergic, beta; Stereoisomerism; Substrate Specificity; Swine | 1986 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
Adrenergic regulation of catecholamine secretion from trout (Oncorhynchus mykiss) chromaffin cells.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Albuterol; Analysis of Variance; Angiotensin II; Animals; Carbachol; Catecholamines; Chromaffin Cells; Clonidine; Dobutamine; Electric Stimulation; Epinephrine; Female; Male; Nadolol; Norepinephrine; Oncorhynchus mykiss; Perfusion; Phentolamine; Phenylephrine; Receptors, Cholinergic; Vasoactive Intestinal Peptide | 2002 |